Skip to main content
Erschienen in:

05.06.2019 | Orthomolekulare Medizin

Magnesium – das unterschätzte Mineral

Rolle von Magnesium im Stoffwechsel und praktische Empfehlungen

verfasst von: Dr. Roland Stegmann

Erschienen in: Journal für Gynäkologische Endokrinologie/Schweiz | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Neben seiner Funktion als Elektrolyt spielt Magnesium eine entscheidende Rolle im Stoffwechsel. Mehr als 700 Enzymsysteme benötigen Magnesium als Kofaktor. Von zentraler Bedeutung ist das Mineral für den Energiestoffwechsel. Zahlreiche Hormone und Neurotransmitter sowie alle Organe und Gewebe sind zum richtigen Funktionieren auf Magnesium angewiesen. Ein Mangel kann sich folglich in ganz unterschiedlichen Formen manifestieren, was seine Erkennung erschweren kann. Dutzende von Symptomen werden mit einem Magnesiummangel in Verbindung gebracht. Erhebungen lassen vermuten, dass Magnesiummangel in der Bevölkerung weiter verbreitet ist als bislang angenommen. Viele Ursachen können dazu beitragen. Zahlreiche Studien zeigen, dass Magnesium bei der Therapie und Prävention vieler Erkrankungen erfolgreich eingesetzt werden kann. Für einen breiteren Einsatz in der Medizin sprechen die hohe Verträglichkeit, das breite therapeutische Spektrum, die einfache Anwendung, das weitgehende Fehlen von Interaktionen mit Medikamenten, die kurze Halbwertszeit und nicht zuletzt der günstige Preis.
Literatur
2.
Zurück zum Zitat Hartwig A (2001) Role of magnesium in genomic stability. Mutat Res 475(1–2):113–121PubMed Hartwig A (2001) Role of magnesium in genomic stability. Mutat Res 475(1–2):113–121PubMed
4.
Zurück zum Zitat Rosanoff A, Weaver CM, Rude RK (2012) Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 70(3):153–164PubMed Rosanoff A, Weaver CM, Rude RK (2012) Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 70(3):153–164PubMed
5.
Zurück zum Zitat Seelig MS (1964) The requirement of magnesium by the normal adult. Am J Clin Nutr 14(6):342–390 Seelig MS (1964) The requirement of magnesium by the normal adult. Am J Clin Nutr 14(6):342–390
6.
Zurück zum Zitat Seelig MS (1981) Magnesium requirements in human nutrition. Magnes Bull 3(Suppl 1a):26–47 Seelig MS (1981) Magnesium requirements in human nutrition. Magnes Bull 3(Suppl 1a):26–47
7.
Zurück zum Zitat Graham L, Caesar J, Burger A (1960) Gastointestinal absorption and excretion of Mg 28 in man. Metabolism 9:646–659PubMed Graham L, Caesar J, Burger A (1960) Gastointestinal absorption and excretion of Mg 28 in man. Metabolism 9:646–659PubMed
8.
Zurück zum Zitat Glei M et al (1995) Magnesium content of foodstuffs and beverages and magnesium intake of adults in Germany. Magnes Bull 17:22–28 Glei M et al (1995) Magnesium content of foodstuffs and beverages and magnesium intake of adults in Germany. Magnes Bull 17:22–28
9.
Zurück zum Zitat Cashman KD, Flynn A (1999) Optimal nutrition: calcium, magnesium and phosphorus. Proc Nutr Soc 58(2):477–487PubMed Cashman KD, Flynn A (1999) Optimal nutrition: calcium, magnesium and phosphorus. Proc Nutr Soc 58(2):477–487PubMed
10.
Zurück zum Zitat Ismail Y, Ismail AA, Ismail AA (2010) The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med 48(3):323–327PubMed Ismail Y, Ismail AA, Ismail AA (2010) The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med 48(3):323–327PubMed
11.
Zurück zum Zitat Mircetić RN et al (2001) Magnesium concentration in plasma, leukocytes and urine of children with intermittent asthma. Clin Chim Acta 312(1–2):197–203PubMed Mircetić RN et al (2001) Magnesium concentration in plasma, leukocytes and urine of children with intermittent asthma. Clin Chim Acta 312(1–2):197–203PubMed
12.
Zurück zum Zitat Mauskop A et al (1993) Deficiency in serum ionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratio. Headache 33(3):135–138PubMed Mauskop A et al (1993) Deficiency in serum ionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratio. Headache 33(3):135–138PubMed
14.
Zurück zum Zitat Chazov EI et al (1974) Taurine and electrical activity of the heart. Circ Res 35(Suppl. 3):11–21PubMed Chazov EI et al (1974) Taurine and electrical activity of the heart. Circ Res 35(Suppl. 3):11–21PubMed
15.
Zurück zum Zitat Bolland MJ et al (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336(7638):262–266PubMedPubMedCentral Bolland MJ et al (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336(7638):262–266PubMedPubMedCentral
16.
Zurück zum Zitat Bolland MJ et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta analysis. BMJ 341:c3691PubMedPubMedCentral Bolland MJ et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta analysis. BMJ 341:c3691PubMedPubMedCentral
17.
Zurück zum Zitat Bolland MJ et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Woman’s Health Initiative Limited Access Dataset and Meta-Analysis. BMJ 342:d2040PubMedPubMedCentral Bolland MJ et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Woman’s Health Initiative Limited Access Dataset and Meta-Analysis. BMJ 342:d2040PubMedPubMedCentral
18.
Zurück zum Zitat Bolland MJ et al (2013) Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf 4(5):199–210PubMedPubMedCentral Bolland MJ et al (2013) Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf 4(5):199–210PubMedPubMedCentral
19.
Zurück zum Zitat Nicoll R, Howard JM, Henein MY (2015) A review of the effect of diet on cardiovascular calcification. Int J Mol Sci 16(4):8861–8883PubMedPubMedCentral Nicoll R, Howard JM, Henein MY (2015) A review of the effect of diet on cardiovascular calcification. Int J Mol Sci 16(4):8861–8883PubMedPubMedCentral
20.
Zurück zum Zitat Hruby A, O’Donnell CJ, Jacques PF et al (2014) Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. Jacc Cardiovasc Imaging 7(1):59–69PubMed Hruby A, O’Donnell CJ, Jacques PF et al (2014) Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. Jacc Cardiovasc Imaging 7(1):59–69PubMed
21.
Zurück zum Zitat Maier JA, Malpuech-Brugere C, Zimowska W et al (2004) Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 1689(1):13–21PubMed Maier JA, Malpuech-Brugere C, Zimowska W et al (2004) Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 1689(1):13–21PubMed
22.
Zurück zum Zitat Labeeuw M et al (1987) Role of magnesium in the physiopathology and treatment of calcium renal lithiasis. Presse Med 16(1):25–27PubMed Labeeuw M et al (1987) Role of magnesium in the physiopathology and treatment of calcium renal lithiasis. Presse Med 16(1):25–27PubMed
23.
Zurück zum Zitat Massey L (2005) Magnesium therapy for nephrolithiasis. Magnes Res 18(2):123–126PubMed Massey L (2005) Magnesium therapy for nephrolithiasis. Magnes Res 18(2):123–126PubMed
24.
Zurück zum Zitat Liao F, Folsom AR, Brancati FL (1998) Is low magnesium concentration a risk factor for coronary heart disease? The atherosclerosis risk in communities (ARIC) study. Am Heart J 136(3):480–490PubMed Liao F, Folsom AR, Brancati FL (1998) Is low magnesium concentration a risk factor for coronary heart disease? The atherosclerosis risk in communities (ARIC) study. Am Heart J 136(3):480–490PubMed
25.
Zurück zum Zitat Ford ES (1999) Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 28(4):645–651PubMed Ford ES (1999) Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 28(4):645–651PubMed
26.
Zurück zum Zitat Del Gobbo LC, Imamura F, Wu JH et al (2013) Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 98(1):160–173PubMedPubMedCentral Del Gobbo LC, Imamura F, Wu JH et al (2013) Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 98(1):160–173PubMedPubMedCentral
27.
Zurück zum Zitat Guasch-Ferre M, Bullo M, Estruch R et al (2014) Dietary magnesium intake is inversely associated with mortality in adults at high cardiovascular disease risk. J Nutr 144(1):55–60PubMed Guasch-Ferre M, Bullo M, Estruch R et al (2014) Dietary magnesium intake is inversely associated with mortality in adults at high cardiovascular disease risk. J Nutr 144(1):55–60PubMed
28.
Zurück zum Zitat Yamori Y, Sagara M, Mizushima S et al (2015) An inverse association between magnesium in 24-h urine and cardiovascular risk factors in middle-aged subjects in 50 CARDIAC Study populations. Hypertens Res 38(3):219–225PubMed Yamori Y, Sagara M, Mizushima S et al (2015) An inverse association between magnesium in 24-h urine and cardiovascular risk factors in middle-aged subjects in 50 CARDIAC Study populations. Hypertens Res 38(3):219–225PubMed
29.
Zurück zum Zitat Kolte D, Vijayaraghavan K, Khera S et al (2014) Role of magnesium in cardiovascular diseases. Cardiol Rev 22(4):182–192PubMed Kolte D, Vijayaraghavan K, Khera S et al (2014) Role of magnesium in cardiovascular diseases. Cardiol Rev 22(4):182–192PubMed
30.
Zurück zum Zitat Kisters K et al (1999) Hypomagnesaemia, borderline hypertension and hyperlipidaemia. Magnes Bull 21:31–34 Kisters K et al (1999) Hypomagnesaemia, borderline hypertension and hyperlipidaemia. Magnes Bull 21:31–34
31.
Zurück zum Zitat Resnick LM et al (2000) Factors affecting blood pressure responses to diet: the Vanguard study. Am J Hypertens 13(9):956–965PubMed Resnick LM et al (2000) Factors affecting blood pressure responses to diet: the Vanguard study. Am J Hypertens 13(9):956–965PubMed
32.
Zurück zum Zitat Rosanoff A, Plesset MR (2013) Oral magnesium supplements decrease high blood pressure (SBP > 155 mm Hg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnes Res 26(3):93–99PubMed Rosanoff A, Plesset MR (2013) Oral magnesium supplements decrease high blood pressure (SBP > 155 mm Hg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnes Res 26(3):93–99PubMed
33.
Zurück zum Zitat Singh RB et al (1991) Does dietary magnesium modulate blood lipids? Biol Trace Elem Res 30(1):59–64PubMed Singh RB et al (1991) Does dietary magnesium modulate blood lipids? Biol Trace Elem Res 30(1):59–64PubMed
34.
Zurück zum Zitat Corica F et al (1994) Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 7(1):43–47PubMed Corica F et al (1994) Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 7(1):43–47PubMed
35.
Zurück zum Zitat Durlach J (1996) Commentary on recent epidemiological and clinical advances. Magnes Res 9(2):139–141PubMed Durlach J (1996) Commentary on recent epidemiological and clinical advances. Magnes Res 9(2):139–141PubMed
36.
Zurück zum Zitat King DE et al (2006) Magnesium supplement intake and C‑reactive protein levels in adults. Nutr Res 26(5):193–196 King DE et al (2006) Magnesium supplement intake and C‑reactive protein levels in adults. Nutr Res 26(5):193–196
37.
Zurück zum Zitat Shechter M et al (2001) Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients. Magnes Res 13(4):275–284 Shechter M et al (2001) Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients. Magnes Res 13(4):275–284
38.
Zurück zum Zitat Parikka HJ, Toivonen LK (1999) Acute effects of intravenous magnesium on ventricular refractoriness and monophasic action potential duration in humans. Scand Cardiovasc J 33(5):300–305PubMed Parikka HJ, Toivonen LK (1999) Acute effects of intravenous magnesium on ventricular refractoriness and monophasic action potential duration in humans. Scand Cardiovasc J 33(5):300–305PubMed
39.
Zurück zum Zitat Thiele R et al (2000) Effect of intravenous magnesium on ventricular tachyarrhythmias associated with acute myocardial infarction. Magnes Res 13(2):111–122PubMed Thiele R et al (2000) Effect of intravenous magnesium on ventricular tachyarrhythmias associated with acute myocardial infarction. Magnes Res 13(2):111–122PubMed
40.
Zurück zum Zitat Ceremuzyński L et al (2000) Hypermagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med 247(1):78–86PubMed Ceremuzyński L et al (2000) Hypermagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med 247(1):78–86PubMed
41.
Zurück zum Zitat Dyckner T, Wester PO (1984) Magnesium deficiency in congestive heart failure. Acta Pharmacol Toxicol (Copenh) 54(Suppl.s1):119–123 Dyckner T, Wester PO (1984) Magnesium deficiency in congestive heart failure. Acta Pharmacol Toxicol (Copenh) 54(Suppl.s1):119–123
42.
Zurück zum Zitat England MR et al (1992) Magnesium administration and dysrhythmias after cardiac surgery. JAMA 268(17):2395–2402PubMed England MR et al (1992) Magnesium administration and dysrhythmias after cardiac surgery. JAMA 268(17):2395–2402PubMed
43.
Zurück zum Zitat Caspi J et al (1995) Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 59(4):942–947PubMed Caspi J et al (1995) Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 59(4):942–947PubMed
44.
Zurück zum Zitat Toraman F et al (2001) Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 72(4):1256–1262PubMed Toraman F et al (2001) Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 72(4):1256–1262PubMed
45.
Zurück zum Zitat Teo KK et al (1991) Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. BMJ 303(6816):1499–1503PubMedPubMedCentral Teo KK et al (1991) Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. BMJ 303(6816):1499–1503PubMedPubMedCentral
46.
Zurück zum Zitat Teo KK, Yusuf S (1993) Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence. Drugs 46(3):347–359PubMed Teo KK, Yusuf S (1993) Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence. Drugs 46(3):347–359PubMed
47.
Zurück zum Zitat Woods KL et al (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339(8809):1553–1558PubMed Woods KL et al (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339(8809):1553–1558PubMed
48.
Zurück zum Zitat Woods KL, Fletcher S (1994) Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 343(8901):816–819PubMed Woods KL, Fletcher S (1994) Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 343(8901):816–819PubMed
49.
Zurück zum Zitat ISIS-4 Collaboration Group (1995) ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58’050 patients with suspected acute myocardial infarction. Lancet 345(8951):669–682 ISIS-4 Collaboration Group (1995) ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58’050 patients with suspected acute myocardial infarction. Lancet 345(8951):669–682
50.
Zurück zum Zitat Seelig MS (1994) Cardiovascular reactions to stress intensified by magnesium deficit, in Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications: a review. J Am Coll Nutr 13(5):429–446PubMed Seelig MS (1994) Cardiovascular reactions to stress intensified by magnesium deficit, in Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications: a review. J Am Coll Nutr 13(5):429–446PubMed
51.
Zurück zum Zitat Chiuve SE, Korngold EC, Januzzi JL Jr. et al (2011) Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 93(2):253–260PubMed Chiuve SE, Korngold EC, Januzzi JL Jr. et al (2011) Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 93(2):253–260PubMed
52.
Zurück zum Zitat Seelig MS (1982) Prenatal and neonatal mineral deficiencies: magnesium, zinc and chromium. In: Lifshitz F (Hrsg) Clinical disorders in Pedriatic nutrition. Marcel Dekker, N.Y., S 167–196 Seelig MS (1982) Prenatal and neonatal mineral deficiencies: magnesium, zinc and chromium. In: Lifshitz F (Hrsg) Clinical disorders in Pedriatic nutrition. Marcel Dekker, N.Y., S 167–196
53.
Zurück zum Zitat Seelig MS (1991) Magnesium in pregnancy: special needs for the adolescent mother. J Am Coll Nutr 10:566 Seelig MS (1991) Magnesium in pregnancy: special needs for the adolescent mother. J Am Coll Nutr 10:566
54.
Zurück zum Zitat Caddel JL (2001) Magnesium deficiency promotes muscle weakness, contribution to the risk of sudden infant death (SIDS) in infants sleeping prone. Magnes Res 14(1–2):39–50 Caddel JL (2001) Magnesium deficiency promotes muscle weakness, contribution to the risk of sudden infant death (SIDS) in infants sleeping prone. Magnes Res 14(1–2):39–50
56.
Zurück zum Zitat Sojka JE, Weaver CM (1995) Magnesium supplementation and osteoporosis. Nutr Rev 53(3):71–74PubMed Sojka JE, Weaver CM (1995) Magnesium supplementation and osteoporosis. Nutr Rev 53(3):71–74PubMed
57.
Zurück zum Zitat Abraham GE, Grewal HA (1990) A total dietary program emphasizing magnesium instead of calcium. Effect on the mineral density of calcaneous bone in postmenopausal women on hormonal therapy. J Reprod Med 35(5):503–507PubMed Abraham GE, Grewal HA (1990) A total dietary program emphasizing magnesium instead of calcium. Effect on the mineral density of calcaneous bone in postmenopausal women on hormonal therapy. J Reprod Med 35(5):503–507PubMed
58.
Zurück zum Zitat Seelig MS (1990) Increased magnesium need with use of combined oestrogen and calcium for osteoporosis treatment. Magnes Res 3(3):197–215PubMed Seelig MS (1990) Increased magnesium need with use of combined oestrogen and calcium for osteoporosis treatment. Magnes Res 3(3):197–215PubMed
59.
Zurück zum Zitat Orchard TS, Larson JC, Alghothani N et al (2014) Magnesium intake, bone mineral density, and fractures: results from the Women’s Health Initiative Observational Study. Am J Clin Nutr 99(4):926–933PubMedPubMedCentral Orchard TS, Larson JC, Alghothani N et al (2014) Magnesium intake, bone mineral density, and fractures: results from the Women’s Health Initiative Observational Study. Am J Clin Nutr 99(4):926–933PubMedPubMedCentral
60.
Zurück zum Zitat Humphries S et al (1999) Low dietary magnesium is associated with insulin resistance in a sample of young, non-diabetic Black Americans. Am J Hypertens 12(8):747–756PubMed Humphries S et al (1999) Low dietary magnesium is associated with insulin resistance in a sample of young, non-diabetic Black Americans. Am J Hypertens 12(8):747–756PubMed
61.
Zurück zum Zitat Alzaid AA et al (1995) Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 80(4):1376–1381PubMed Alzaid AA et al (1995) Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 80(4):1376–1381PubMed
62.
Zurück zum Zitat Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G et al (2004) Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 30(3):253–258PubMed Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G et al (2004) Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 30(3):253–258PubMed
63.
Zurück zum Zitat Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M et al (2016) A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 111:272–282PubMed Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M et al (2016) A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 111:272–282PubMed
64.
Zurück zum Zitat de Lourdes Lima M et al (1998) The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21(5):682–686 de Lourdes Lima M et al (1998) The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21(5):682–686
65.
Zurück zum Zitat Engelen W et al (2000) Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy? Magnes Res 13(3):197–203PubMed Engelen W et al (2000) Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy? Magnes Res 13(3):197–203PubMed
66.
Zurück zum Zitat Ma E et al (2010) High dietary intake of magnesium may decrease risk of colorectal cancer in Japanese men. J Nutr 140(4):779–785PubMed Ma E et al (2010) High dietary intake of magnesium may decrease risk of colorectal cancer in Japanese men. J Nutr 140(4):779–785PubMed
67.
Zurück zum Zitat Wark PA, Lau R, Norat T et al (2012) Magnesium intake and colorectal tumor risk: a case-control study and meta-analysis. Am J Clin Nutr 96(3):622–631PubMed Wark PA, Lau R, Norat T et al (2012) Magnesium intake and colorectal tumor risk: a case-control study and meta-analysis. Am J Clin Nutr 96(3):622–631PubMed
68.
Zurück zum Zitat Dibaba D, Xun P, Yokota K et al (2015) Magnesium intake and incidence of pancreatic cancer: the VITamins and Lifestyle study. Br J Cancer 113(11):1615–1621PubMedPubMedCentral Dibaba D, Xun P, Yokota K et al (2015) Magnesium intake and incidence of pancreatic cancer: the VITamins and Lifestyle study. Br J Cancer 113(11):1615–1621PubMedPubMedCentral
69.
Zurück zum Zitat Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083PubMedPubMedCentral Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083PubMedPubMedCentral
70.
Zurück zum Zitat Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 47(13):1928–1937PubMed Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 47(13):1928–1937PubMed
71.
Zurück zum Zitat Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134(1):95–101PubMed Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134(1):95–101PubMed
72.
Zurück zum Zitat Song S, Wang B, Zhang X et al (2015) Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a Meta-analysis. PLoS ONE 10(7):e134321PubMedPubMedCentral Song S, Wang B, Zhang X et al (2015) Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a Meta-analysis. PLoS ONE 10(7):e134321PubMedPubMedCentral
73.
Zurück zum Zitat Batabyal P, Vander Hoorn S, Christophi C et al (2014) Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol 21(7):2453–2462PubMed Batabyal P, Vander Hoorn S, Christophi C et al (2014) Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol 21(7):2453–2462PubMed
74.
Zurück zum Zitat Stolzenberg-Solomon RZ, Graubard BI, Chari S et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872–2878PubMed Stolzenberg-Solomon RZ, Graubard BI, Chari S et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872–2878PubMed
75.
Zurück zum Zitat Wolpin BM, Bao Y, Qian ZR et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 105(14):1027–1035PubMedPubMedCentral Wolpin BM, Bao Y, Qian ZR et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 105(14):1027–1035PubMedPubMedCentral
76.
Zurück zum Zitat Evans JM, Donnelly LA, Emslie-Smith AM et al (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304–1305PubMedPubMedCentral Evans JM, Donnelly LA, Emslie-Smith AM et al (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304–1305PubMedPubMedCentral
77.
Zurück zum Zitat Lee MS, Hsu CC, Wahlqvist ML et al (2011) Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer 11:20PubMedPubMedCentral Lee MS, Hsu CC, Wahlqvist ML et al (2011) Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer 11:20PubMedPubMedCentral
78.
Zurück zum Zitat Wang LW, Li ZS, Zou DW et al (2008) Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 14(47):7192–7198PubMedPubMedCentral Wang LW, Li ZS, Zou DW et al (2008) Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 14(47):7192–7198PubMedPubMedCentral
79.
Zurück zum Zitat Sherwood RA et al (1986) Magnesium and the premenstrual syndrome. Ann Clin Biochem 23(6):667–670PubMed Sherwood RA et al (1986) Magnesium and the premenstrual syndrome. Ann Clin Biochem 23(6):667–670PubMed
80.
Zurück zum Zitat Posaci C et al (1994) Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 73(6):452–455PubMed Posaci C et al (1994) Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 73(6):452–455PubMed
81.
Zurück zum Zitat Muneyvirci-Delale O et al (1998) Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women. Fertil Steril 69(5):958–962PubMed Muneyvirci-Delale O et al (1998) Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women. Fertil Steril 69(5):958–962PubMed
82.
Zurück zum Zitat Werbach M (1995) Premenstrual syndrome: magnesium. Townsend Lett Dr 13:26 Werbach M (1995) Premenstrual syndrome: magnesium. Townsend Lett Dr 13:26
83.
Zurück zum Zitat Facchinetti F et al (1991) Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol Clin North Am 78(2):177–181 Facchinetti F et al (1991) Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol Clin North Am 78(2):177–181
84.
Zurück zum Zitat Benassi L et al (1992) Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol 19(3):176–179PubMed Benassi L et al (1992) Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol 19(3):176–179PubMed
85.
Zurück zum Zitat Fontana-Klaiber H, Hogg B (1990) Therapeutische Wirkung von Magnesium bei Dysmenorroe. Schweiz Rundsch Med Prax 79(16):491–494PubMed Fontana-Klaiber H, Hogg B (1990) Therapeutische Wirkung von Magnesium bei Dysmenorroe. Schweiz Rundsch Med Prax 79(16):491–494PubMed
86.
Zurück zum Zitat Seifert B et al (1989) Magnesium – a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol 111(11):755–760PubMed Seifert B et al (1989) Magnesium – a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol 111(11):755–760PubMed
87.
Zurück zum Zitat Goldberg B (1998) Alternative medicine guide: women’s health series 1. Future Medicine Publishing, Tiburon Goldberg B (1998) Alternative medicine guide: women’s health series 1. Future Medicine Publishing, Tiburon
88.
Zurück zum Zitat Edorh AP et al (2003) Magnesium content in seminal fluid as an indicator of chronic prostatitis. Cell Mol Biol 49:419–423 Edorh AP et al (2003) Magnesium content in seminal fluid as an indicator of chronic prostatitis. Cell Mol Biol 49:419–423
89.
Zurück zum Zitat Seelig MS (1994) Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications: a review. J Am Coll Nutr 13(5):429–446. www.mgwater.com PubMed Seelig MS (1994) Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications: a review. J Am Coll Nutr 13(5):429–446. www.​mgwater.​com PubMed
90.
Zurück zum Zitat Conradt A, Weidinger AH (1982) The central position of magnesium in the management of fetal hypotrophy—a contribution to the pathomechanism of utero-placental insufficiency, prematurity and poor intrauterine fetal growth as well as pre-eclampsia. Magnes Bull 4:103–124 Conradt A, Weidinger AH (1982) The central position of magnesium in the management of fetal hypotrophy—a contribution to the pathomechanism of utero-placental insufficiency, prematurity and poor intrauterine fetal growth as well as pre-eclampsia. Magnes Bull 4:103–124
91.
Zurück zum Zitat Handwerker SM et al (1993) Ionized serum magnesium levels in umbilical cord blood of normal pregnant women at delivery: relationship to calcium, demographics and birthweight. Am J Perinatol 10(5):392–397PubMed Handwerker SM et al (1993) Ionized serum magnesium levels in umbilical cord blood of normal pregnant women at delivery: relationship to calcium, demographics and birthweight. Am J Perinatol 10(5):392–397PubMed
92.
Zurück zum Zitat Handwerker SM, Altura BT, Altura BM (1996) Serum ionized magnesium and other electrolytes in the antenatal period of human pregnancy. J Am Coll Nutr 15(1):36–43PubMed Handwerker SM, Altura BT, Altura BM (1996) Serum ionized magnesium and other electrolytes in the antenatal period of human pregnancy. J Am Coll Nutr 15(1):36–43PubMed
93.
Zurück zum Zitat Almonte RA et al (1999) Gestational magnesium deficiency is deleterious to fetal outcome. Biol Neonate 76(1):26–32PubMed Almonte RA et al (1999) Gestational magnesium deficiency is deleterious to fetal outcome. Biol Neonate 76(1):26–32PubMed
94.
Zurück zum Zitat Peikert A, Wilimzig C, Köhne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalagia 16(4):257–263 Peikert A, Wilimzig C, Köhne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalagia 16(4):257–263
95.
Zurück zum Zitat Chiu HY, Yeh TH, Huang YC et al (2016) Effects of intravenous and oral magnesium on reducing migraine: a Meta-analysis of randomized controlled trials. Pain Physician 19(1):E97–E112PubMed Chiu HY, Yeh TH, Huang YC et al (2016) Effects of intravenous and oral magnesium on reducing migraine: a Meta-analysis of randomized controlled trials. Pain Physician 19(1):E97–E112PubMed
96.
Zurück zum Zitat Mauskop A, Varughese J (2012) Why all migraine patients should be treated with magnesium. J Neural Transm (vienna) 119(5):575–579 Mauskop A, Varughese J (2012) Why all migraine patients should be treated with magnesium. J Neural Transm (vienna) 119(5):575–579
97.
Zurück zum Zitat Talebi M, Savadi-Oskouei D, Farhoudi M et al (2011) Relation between serum magnesium level and migraine attacks. Neurosciences (Riyadh) 16(4):320–323 Talebi M, Savadi-Oskouei D, Farhoudi M et al (2011) Relation between serum magnesium level and migraine attacks. Neurosciences (Riyadh) 16(4):320–323
98.
Zurück zum Zitat Charles AC, Baca SM (2013) Cortical spreading depression and migraine. Nat Rev Neurol 9(11):637–644PubMed Charles AC, Baca SM (2013) Cortical spreading depression and migraine. Nat Rev Neurol 9(11):637–644PubMed
99.
Zurück zum Zitat Sun-Edelstein C, Mauskop A (2009) Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 9(3):369–379PubMed Sun-Edelstein C, Mauskop A (2009) Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 9(3):369–379PubMed
100.
Zurück zum Zitat Mauskop A et al (1995) Intravenous magnesium sulfate relieves cluster headache in patients with low serum ionized magnesium levels. Headache 35(10):597–600PubMed Mauskop A et al (1995) Intravenous magnesium sulfate relieves cluster headache in patients with low serum ionized magnesium levels. Headache 35(10):597–600PubMed
101.
Zurück zum Zitat Werbach MR (1995) Nutritional influences on aggressive behavior. J Orthomol Med 7(1):45–51 Werbach MR (1995) Nutritional influences on aggressive behavior. J Orthomol Med 7(1):45–51
102.
Zurück zum Zitat Cox RH, Shealy CN et al (1996) Significant magnesium deficiency in depression. J Neur Orth Med Surg 17:7–9 Cox RH, Shealy CN et al (1996) Significant magnesium deficiency in depression. J Neur Orth Med Surg 17:7–9
103.
Zurück zum Zitat Seelig MS (1998) Review and hypothesis: might patients with the chronic fatigue syndrome have latent tetany of magnesium deficiency. J Chronic Fatigue Syndr 4(2):77–108 Seelig MS (1998) Review and hypothesis: might patients with the chronic fatigue syndrome have latent tetany of magnesium deficiency. J Chronic Fatigue Syndr 4(2):77–108
104.
Zurück zum Zitat Cox IM et al (1991) Red blood cell magnesium and chronic fatigue syndrome. Lancet 337(8744):757–760PubMed Cox IM et al (1991) Red blood cell magnesium and chronic fatigue syndrome. Lancet 337(8744):757–760PubMed
105.
Zurück zum Zitat Vink R, Nechifor M (2011) Magnesium in the central nervous system. University of Adelaide Press, Adelaide Vink R, Nechifor M (2011) Magnesium in the central nervous system. University of Adelaide Press, Adelaide
106.
Zurück zum Zitat Gröber U, Kisters K (2017) Arzneimittel als Mikronährstoffräuber, 2. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart Gröber U, Kisters K (2017) Arzneimittel als Mikronährstoffräuber, 2. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart
107.
Zurück zum Zitat Andersen G (2011) Lebensmitteltabelle für die Praxis, 5. Aufl. Der kleine Souci/Fachmann/Kraut. Wissenschaftliche Verlagsgesellschaft, Stuttgart Andersen G (2011) Lebensmitteltabelle für die Praxis, 5. Aufl. Der kleine Souci/Fachmann/Kraut. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Metadaten
Titel
Magnesium – das unterschätzte Mineral
Rolle von Magnesium im Stoffwechsel und praktische Empfehlungen
verfasst von
Dr. Roland Stegmann
Publikationsdatum
05.06.2019
Verlag
Springer Vienna
Erschienen in
Journal für Gynäkologische Endokrinologie/Schweiz / Ausgabe 2/2019
Print ISSN: 1995-6924
Elektronische ISSN: 2520-8500
DOI
https://doi.org/10.1007/s41975-019-0092-2

Weitere Artikel der Ausgabe 2/2019

Journal für Gynäkologische Endokrinologie/Schweiz 2/2019 Zur Ausgabe

Neues aus der Schweizerischen Menopausengesellschaft/SMG

Neues aus der Schweizerischen Menopausengesellschaft / SMG

Editorial

Editorial

Blick über den Tellerrand

Menopause und Energiesystemanalyse